Cumberland Pharmaceuticals Inc

Go to Cumberland Pharmaceuticals Inc Website

$3.79

0.00 (0.00%)
Live
Previous Close

$3.79

Day Range

$0 - $0

Previous Day Range

$3.63 - $4.095

Market Cap

$60.0 million USD

Day Vol.

0

Previous Day Vol.

73321

Currency

USD

Primary Exchange

Nasdaq

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutic...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

The Duchenne muscular dystrophy market is experiencing steady growth driven by advancements in gene therapies, exon-skipping drugs, and emerging treatment options. Key players are expanding pipelines with novel therapies in late-stage clinical trials, with potential market transformation expected between 2025-2034.

Related tickers: CAPR, SRPT, RGNX, CPIX, NPPNY.

Read Full Article

The dilated cardiomyopathy market is experiencing steady growth, driven by rising prevalence of heart failure, improved diagnostic techniques, and advancements in genetic testing. Increasing R&D investment in gene therapies and novel drug candidates is expanding treatment options.

Related tickers: AMGN, BMY, CELGr, CPIX, RCKT, RCKTW, SLDB.

Read Full Article
Trending Tickers

Please sign in to view